This inventor holds 1 USPTO granted patent. Top assignees: Ajou University Industry-Academic Cooperation Foundation, The Catholic University of Korea Industry-Academic Cooperation Foundation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Tae Geon Oh: Innovator in Radiation Treatment Quality Assurance
Introduction
Tae Geon Oh is a notable inventor based in Namyangju-si, South Korea. He has made significant contributions to the field of radiation treatment through his innovative patent. His work focuses on enhancing the efficiency of dose delivery quality assurance, which is crucial for high-precision radiation therapy.
Latest Patents
Tae Geon Oh holds a patent for a "Method and apparatus for carrying out dose delivery quality assurance for high-precision radiation treatment." This patent outlines a method that utilizes regression analysis to derive parameters affecting the pass rate of dose delivery quality assurance. The invention allows for the prediction of whether the quality assurance will pass based on these parameters, thereby improving the efficiency and speed of radiation treatment for patients. He has 1 patent to his name.
Career Highlights
Throughout his career, Tae Geon Oh has worked with esteemed institutions, including the Catholic University of Korea Industry-Academic Cooperation Foundation and Ajou University Industry-Academic Cooperation Foundation. His experience in these organizations has contributed to his expertise in the field of radiation treatment.
Collaborations
Tae Geon Oh has collaborated with notable colleagues, including Young Nam Kang and Ji Na Kim. Their joint efforts have further advanced the research and development of innovative solutions in radiation therapy.
Conclusion
Tae Geon Oh's contributions to radiation treatment quality assurance demonstrate his commitment to improving patient care through innovation. His patent reflects a significant advancement in the field, showcasing the importance of research and collaboration in developing effective medical technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile